Daiichi Sankyo
Katie Raustad is a seasoned professional with extensive experience in project management and leadership within the biopharmaceutical and academic sectors. Currently serving as the Senior Director of Global Project Management and Leadership at Daiichi Sankyo, Inc., Katie previously held significant roles including Director of Global Project Management and Leadership at Sema4, where key contributions included successfully leading the company's separation from the Mount Sinai Hospital System. Additional experience encompasses positions at the Icahn School of Medicine at Mount Sinai and Merck, focusing on oncology, clinical diagnostics, and strategic project development. Katie holds a Master's Degree in Biology from Rutgers University and a Bachelor's Degree in Animal Sciences from the University of Delaware.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.